LabCorp Acquires Covance Genomics Laboratory
LabCorp has acquired Covance Genomics Laboratory and its associated genomic analysis business.
LabCorp has acquired Covance Genomics Laboratory and its associated genomic analysis business. The laboratory is located in Seattle and provides complex genomic analysis, including gene expression array studies and next generation sequencing applications. As part of the acquisition, LabCorp and Covance have entered into a five-year services agreement to collaborate and continue offering specialty genomic services to Covance clients. The existing 50 employees, both scientists and staff, are now LabCorp employees.
Read the full release here.
Reaching Diverse Patient Populations With Personalized Treatment Methods
January 20th 2025Daejin Abidoye, head of solid tumors, oncology development, AbbVie, discusses a number of topics around diversity in clinical research including industry’s greatest challenges in reaching diverse patient populations, personalized treatment methods, recruitment strategies, and more.
Optimizing Phase III Oncology Trial Recruitment with Data-Driven Insights
February 3rd 2025A pharmaceutical company aimed to launch a Phase III clinical trial for a new oncology drug, focusing on efficient and effective patient recruitment across diverse regions. They evaluated patient populations by analyzing demographics, social determinants of health, and geography. Investigator profiling included practice details, affiliations, referral networks, and clinical trial experience. The final step involved selecting and extracting target lists for implementation.
